Sitagliptin/metforminklorid APC 50 mg/500 mg tablete s prilagođenim oslobađanjem
| Name | Sitagliptin/metforminklorid APC 50 mg/500 mg tablete s prilagođenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-852627985 |
| Active Substance | sitagliptinklorid hidrat metforminklorid |
| Composition | svaka tableta sadrži 50 mg sitagliptina u obliku sitagliptinklorid hidrata i 500 mg metforminklorida. |
| Pharmaceutical Form | tableta s prilagođenim oslobađanjem |
| Manufacturer | Adamed Pharma S.A., Pabianice, Poljska |
| Marketing Authorisation Holder | APC Instytut Sp. z o.o., Ul. Aleje Jerozolimskie 146c, Varšava, Mazowieckei, Poljska |
| Marketing Authorisation Date | 01.06.2022 |
| MA Period of Validity | 01.06.2027 |
| Classification Number | UP/I-530-09/20-01/204 |
| Registration Number | 381-12-01/70-22-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A10BD07 |
| Marketing status | nije stavljeno u promet |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
